Abstract
We report on the successful treatment with sildenafil of a unique case of severe chronic thromboembolic pulmonary hypertension which developed as a late complication in a 71-year-old heart transplant recipient, with focus on the potential therapeutic challenges encountered in the management of such a peculiar association of clinical conditions.
Copyright © 2010 S. Karger AG, Basel.
MeSH terms
-
Aged
-
Antihypertensive Agents / adverse effects
-
Antihypertensive Agents / therapeutic use*
-
Heart Transplantation*
-
Humans
-
Hypertension, Pulmonary / drug therapy*
-
Hypertension, Pulmonary / etiology
-
Male
-
Phosphodiesterase 5 Inhibitors / adverse effects
-
Phosphodiesterase 5 Inhibitors / therapeutic use*
-
Piperazines / adverse effects
-
Piperazines / therapeutic use*
-
Pulmonary Embolism / drug therapy*
-
Pulmonary Embolism / physiopathology
-
Purines / adverse effects
-
Purines / therapeutic use
-
Sildenafil Citrate
-
Sulfones / adverse effects
-
Sulfones / therapeutic use*
-
Treatment Outcome
Substances
-
Antihypertensive Agents
-
Phosphodiesterase 5 Inhibitors
-
Piperazines
-
Purines
-
Sulfones
-
Sildenafil Citrate